Fructose-1,6-diphosphate and a glucose-free solution enhances functional recovery in hypothermic heart preservation

被引:26
作者
Chien, S
Zhang, FT
Niu, WY
Ehringer, W
Chiang, B
Shi, XJ
Gray, LA
机构
[1] Univ Louisville, Jewish Hosp Cardiothorac Surg Res Inst, Dept Surg, Louisville, KY 40292 USA
[2] Univ Louisville, Ctr Appl Microcirculatory Res, Louisville, KY 40292 USA
关键词
D O I
10.1016/S1053-2498(99)00142-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fructose-1,6-diphosphate (FDP) has been shown to protect tissue during hypoxia under various ischemic conditions, including isolated heart perfusion. We tested the hypothesis that adding FDP to St. Thomas solution can extend hypothermic heart preservation time. Methods: Sixteen adult Sprague-Dawley rats were used. Under general anesthesia, the hearts were removed and preserved at 4 degrees C in St. Thomas solution (30 ml/kg) for 12 hours. FDP (5 mM) was added to the St. Thomas solution in the study group (n = 8), whereas no FDP was used in the control group (n = 10). The hearts were reperfused after 12 hours of preservation using a working heart model. Results: In the study group, cardiac output ranged from 13.00 +/- 2.34 to 17.66 +/- 1.71 ml/min, maximum aortic flow was 3.40 +/- 1.99 to 9.26 +/- 1.72 ml/min, left ventricular stroke volume ranged from 0.074 +/- 0.014 to 0.092 +/- 0.009 ml, left ventricular stroke work ranged from 6.22 +/- 0.39 to 7.95 +/- 0.44 ml/mmHg, and maximum left ventricular generated power was 14.38 +/- 2.94 to 20.16 +/- 2.49 Joules/min. All of these parameters were higher than those in the control group (p < 0.001). Coronary vascular resistance and myocardial tissue wet/dry weight ratio were lower in the study group than in the control group (p < 0.05). Conclusions: Heart function was better preserved when FDP was added to St. Thomas solution during hypothermic rat heart preservation. The mechanism is not totally clear, but enhancement of high-energy phosphate production during ischemia is possible.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 60 条
  • [1] FRUCTOSE-1,6-DIPHOSPHATE OR ADENOSINE ATTENUATE LEUKOCYTE ADHERENCE IN POSTISCHEMIC SKELETAL-MUSCLE
    AKIMITSU, T
    WHITE, JA
    CARDEN, DL
    GUTE, DC
    KORTHUIS, RJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (05): : H1743 - H1751
  • [2] FRUCTOSE-1,6-DIPHOSPHATE FAILS TO LIMIT EARLY MYOCARDIAL-INFARCTION SIZE IN A CANINE MODEL
    ANGELOS, MG
    LEASURE, JE
    BARTON, RL
    [J]. ANNALS OF EMERGENCY MEDICINE, 1993, 22 (02) : 171 - 177
  • [3] Bickler PE, 1996, J NEUROCHEM, V67, P1463
  • [4] MYOCARDIAL BLOOD-FLOW AND HEMODYNAMIC-RESPONSES TO EXERCISE TRAINING IN DOGS
    BOVE, AA
    HULTGREN, PB
    RITZER, TF
    CAREY, RA
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1979, 46 (03) : 571 - 578
  • [5] HEMORHEOLOGICAL EFFECTS OF FRUCTOSE-1,6-DIPHOSPHATE IN PATIENTS WITH LOWER-EXTREMITY ISCHEMIA
    CACIOLI, D
    CLIVATI, A
    PELOSI, P
    MEGEVAND, J
    GALEONE, M
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1988, 10 (10) : 668 - 674
  • [6] CEREBRAL RESUSCITATION WITH SUCCINATE AND FRUCTOSE-1, 6-DIPHOSPHATE
    CANNELLA, DM
    KAPP, JP
    MUNSCHAUER, FE
    MARKOV, AK
    SHUCARD, DW
    [J]. SURGICAL NEUROLOGY, 1989, 31 (03): : 177 - 182
  • [7] Fructose-1,6-diphosphate: Potential protection in cyclosporine-induced renal impairment
    Cardoso, LR
    Santos, OFP
    Boim, MA
    Barros, EG
    Ajzen, H
    Schor, N
    [J]. NEPHRON, 1996, 72 (01): : 67 - 71
  • [8] ROLE OF TIMING OF ADMINISTRATION IN THE CARDIOPROTECTIVE EFFECT OF FRUCTOSE-1,6-BISPHOSPHATE
    CARGNONI, A
    CONDORELLI, E
    BORASO, A
    COMINI, L
    DEGIULI, F
    PASINI, E
    FERRARI, R
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1992, 6 (03) : 209 - 217
  • [9] CAVALLINI L, 1992, BIOCHEM PHARMACOL, V7, P1539
  • [10] PROTECTIVE EFFECTS OF FRUCTOSE-1,6-DIPHOSPHATE ON ACUTE AND CHRONIC DOXORUBICIN CARDIOTOXICITY IN RATS
    DANESI, R
    BERNARDINI, N
    MARCHETTI, A
    BERNARDINI, M
    DELTACCA, M
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) : 326 - 332